|
|
Volumn 343, Issue 13, 2000, Pages 963-964
|
|
Moving beyond fluorouracil for colorectal cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DNA TOPOISOMERASE INHIBITOR;
FLUOROURACIL;
FOLINIC ACID;
IRINOTECAN;
OXALIPLATIN;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
COLORECTAL CANCER;
DRUG EFFICACY;
DRUG MECHANISM;
EDITORIAL;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
PRIORITY JOURNAL;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
COLORECTAL NEOPLASMS;
DIARRHEA;
DRUG ADMINISTRATION SCHEDULE;
FLUOROURACIL;
HUMAN;
LEUCOVORIN;
NEOPLASM METASTASIS;
NEUTROPENIA;
|
|
EID: 0034727053
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200009283431309 Document Type: Editorial |
|
Times cited : (31)
|
|
References (10)
|
